Intraocular Injections (Anti-VEGF)

The retina, which lines the inner surface of our eye and transmits visual signals to the brain, possesses a flawless network of blood circulation. However, when this network becomes diseased due to aging, genetic factors, or systemic issues like diabetes, unwanted and fragile new blood vessels begin to form. Until twenty years ago, this destructive process often resulted in "certain blindness." Today, thanks to Intraocular Injections (Anti-VEGF Therapy)—one of the greatest breakthroughs in medicine—this process can be successfully halted.

As Ophthalmology Specialist Ayşe Öner and her elite clinical team, highly experienced in medical retina, we intervene in these emergencies using the latest generation of FDA and EMA-approved molecules. By combining Turkey’s steadfast vision in health tourism with our clinic’s VIP service standards, we offer international patients an "immediate intervention" opportunity, bypassing long waiting lists in their home countries for a comfortable and stress-free healing experience.

What is Anti-VEGF Therapy?

When tissues in our body sense a lack of oxygen, they release a protein called Vascular Endothelial Growth Factor (VEGF) to create new blood vessels. While usually beneficial, this protein can go out of control in certain eye diseases. This overproduction leads to the formation of fragile, abnormal new vessels (neovascularization) under the retina. These "leaky" vessels constantly bleed and leak fluid (edema), essentially "drowning" the visual center (macula).

Anti-VEGF medications are smart molecules designed to block and neutralize this harmful protein. Injected into the eye in millimetric doses, these drugs:

1. Rapidly stop abnormal vessel growth.
2. Dry up existing hemorrhages.
3. Reduce edema (swelling) in the macula to protect and, in many cases, significantly increase the patient's vision.

Targeted Conditions

Intraocular injections are life-saving interventions for three primary disease groups characterized by cellular-level bleeding and edema:

1. Wet-Type Age-Related Macular Degeneration (Yellow Spot Disease): A much more aggressive form than the dry type, where bleeding occurs under the macula. Anti-VEGF is the global gold-standard treatment.
2. Diabetic Macular Edema: When years of diabetes damage the capillaries behind the eye, leading to fluid leakage in the visual center. Injections restore reading and detail vision.
3. Retinal Vein Occlusion (Eye Stroke): When a blood clot blocks the main vein of the retina, causing extensive bleeding. The medication is applied to stop the bleeding and resolve the resulting crisis-level edema.

The Procedure: Painless and Rapid

The idea of a "needle in the eye" can understandably cause anxiety. However, in our clinic, this procedure is more comfortable than a standard blood draw. It is entirely painless and takes only a few seconds.

1. Preparation: The eye surface is completely numbed using only anesthetic drops. No needles or general anesthesia are required. The area is then sterilized with special solutions.
2. The Injection: Using specialized micro-needles thinner than a human hair, Dr. Ayşe Öner delivers the medication into the vitreous cavity through the white of the eye (sclera).
3. Sensation: Patients feel only a slight touch or pressure, not pain. The actual injection lasts just 2-3 seconds.
4. Recovery: There are no stitches or bandages. Patients can walk out of the clinic immediately and return to their daily lives, using only antibiotic drops for a few days.

Treatment Protocol: The Importance of Continuity

Intraocular injections are not a one-time "miracle cure" but a management process for chronic conditions. Typically, a "Loading Dose" of three injections (one per month) is applied to break the severity of the disease.

Following this, we adopt the modern "Treat and Extend" approach. Based on results from OCT (Optical Coherence Tomography) scans, we gradually extend the intervals between injections (to 2, 3, or 4 months) to minimize the patient's travel burden while maintaining maximum vision.

The VIP Advantage with Dr. Ayşe Öner

Retinal bleeding and edema are medical emergencies that cannot wait. Waiting 2-3 months for a public hospital appointment in Europe or elsewhere can mean permanent, irreversible blindness. Our clinic provides a "Rapid Access Ecosystem" for health tourism:

1. Zero Waiting, Instant Treatment: Your program begins the moment you book your flight. On the day you arrive, advanced OCT and Eye Angiography (FFA) tests are performed. If a leak is detected, the injection is performed that same day.
2. Access to Premium Molecules: We maintain a constant stock of the world's most advanced, long-acting Anti-VEGF molecules (such as Brolucizumab and Faricimab).
3. Seamless Logistics: We manage VIP airport greetings, luxury accommodation near the clinic, and private transfers so you can focus entirely on your recovery.
4. Global Follow-up: Your treatment plan is explained in your native language. When you return home, you can upload your local OCT scans to our online system for remote evaluation by Dr. Ayşe Öner, allowing us to plan your next "healing vacation" with precision.

Do not let retinal leakage darken your world or bureaucratic queues steal your light. Contact our international patient coordination unit today to protect your vision with the most advanced molecules and VIP standards of care. Every vision saved is priceless.